HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $133 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on BioNTech (NASDAQ:BNTX) and maintained a price target of $133.
November 27, 2023 | 12:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst reaffirms Buy rating and $133 price target for BioNTech (BNTX).
The reiteration of a Buy rating and maintenance of a price target by a reputable analyst like Robert Burns could instill confidence in investors and positively influence BioNTech's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100